These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3054014)

  • 1. Isolation and in vitro growth of glioma-infiltrating lymphocytes, and an analysis of their surface phenotypes.
    Sawamura Y; Abe H; Aida T; Hosokawa M; Kobayashi H
    J Neurosurg; 1988 Nov; 69(5):745-50. PubMed ID: 3054014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation and expansion of glioma-infiltrating lymphocytes in vitro: an analysis of their surface phenotypes and antitumor activities].
    Sawamura Y
    Hokkaido Igaku Zasshi; 1991 Nov; 66(6):868-78. PubMed ID: 1783372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity and surface phenotypes of human glioma-infiltrating lymphocytes after in vitro expansion in the presence of interleukin 2.
    Sawamura Y; Hosokawa M; Kuppner MC; Kobayashi H; Aida T; Abe H; de Tribolet N
    Cancer Res; 1989 Apr; 49(7):1843-9. PubMed ID: 2784352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of cytolytic activity and cell surface phenotypes of lymphokine activated killer cells stimulated with R-IL 2 and an anti-CD 3 antibody].
    Kikuchi T; Sakai H; Nakamura N; Watanabe M; Ohno T
    No To Shinkei; 1990 Jun; 42(6):575-80. PubMed ID: 2119634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers.
    Miescher S; Whiteside TL; de Tribolet N; von Fliedner V
    J Neurosurg; 1988 Mar; 68(3):438-48. PubMed ID: 3257792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
    Tilden AB; Itoh K; Balch CM
    J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Separation and functional analysis of tumor-infiltrating lymphocytes in brain tumor tissues].
    Saito T; Tanaka R; Takai N; Hara N; Yoshida S
    No To Shinkei; 1988 Dec; 40(12):1137-42. PubMed ID: 3266842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
    Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
    Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of lymphoid cells isolated from human gliomas.
    Farmer JP; Antel JP; Freedman M; Cashman NR; Rode H; Villemure JG
    J Neurosurg; 1989 Oct; 71(4):528-33. PubMed ID: 2795172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
    J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of mixed lymphocyte-tumor culture in patients with malignant brain tumor.
    Yoshida S; Tanaka R; Ono M; Takai N; Saito T
    J Neurosurg; 1989 Sep; 71(3):398-402. PubMed ID: 2527972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.
    Belldegrun A; Muul LM; Rosenberg SA
    Cancer Res; 1988 Jan; 48(1):206-14. PubMed ID: 3257161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and functional characterization of tumor infiltrating lymphocytes in mycosis fungoides: continuous growth of CD4+ CD45R+ T-cell clones with suppressor-inducer activity.
    Reinhold U; Pawelec G; Fratila A; Leippold S; Bauer R; Kreysel HW
    J Invest Dermatol; 1990 Mar; 94(3):304-9. PubMed ID: 2137847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
    Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
    J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro generation and antitumor activity of adherent lymphokine-activated killer cells from the blood of patients with brain tumors.
    Whiteside TL; Wang YL; Selker RG; Herberman RB
    Cancer Res; 1988 Nov; 48(21):6069-75. PubMed ID: 2971433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomagnetic separation of infiltrating T lymphocytes from brain tumors.
    Bosnes V; Hirschberg H
    J Neurosurg; 1989 Aug; 71(2):218-23. PubMed ID: 2664096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.
    Wong JT; Pinto CE; Gifford JD; Kurnick JT; Kradin RL
    J Immunol; 1989 Nov; 143(10):3404-11. PubMed ID: 2509557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity, growth, and phenotype of long-term IL-2 cultures of human NK and T lymphocytes.
    Fuchshuber PR; Lotzová E; Pollock RE
    Lymphokine Cytokine Res; 1991 Apr; 10(1-2):51-9. PubMed ID: 1651770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.